Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  urelumab
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Study of the Safety and Tolerability of Urelumab Administered in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkins Lymphoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CA186-107, NCI-2014-02119, 2014-002241-22, NCT02253992
Urelumab and Rituximab in Treating Patients with Relapsed, Refractory, or High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2014-0932, NCI-2015-00805, NCT02420938
Anti-LAG-3 or Urelumab Alone and in Combination with Nivolumab in Treating Patients with Recurrent Glioblastoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ABTC-1501, NCI-2015-01914, 1501, NCT02658981
Start Over